Objective : Intraarterial thrombolysis (IA-Tx) with stent retriever is accepted as an additional treatment for selected patients and the clinical benefit is well reported. Each intravenous tissue plasminogen activator administration (IV-tPA) and perfusion diffusion mismatching (P/D-mismatching) is well known the beneficial effects for recanalization and clinical outcomes. In this report, authors analyzed the clinical outcomes of additional IA-Tx with retrieval stent device, according to the combined IV-tPA and P/D-mismatching or not.
INTRODUCTION
Early reperfusion of the penumbra area in patients with acute ischemic stroke is critical, for ischemic stroke patients with large vessel occlusion.
2)30)31) Recanalization of the occluded artery after intravenous tissue plasminogen activator (IV-tPA) administration is strongly associated with a better neurologic outcome, but large thrombus burden in a large vessel can limit recanalization and increase the risk for hemorrhages. 
MATERIALS AND METHODS
The treatment protocol ( Fig. 1 Time to puncture Mean ± SD 5.6 ± 1.7 6.5 ± 3.5 5.1 ± 1. Eighty-one patients with large vessel, anterior circulation occlusion who treated using Solitaire revascularization devices were analyzed (Table 1) (Table 1) .
30)
Neuro-radiological evaluations 
Statistical analyses
All data are presented as a mean ± standard devia- 
RESULTS

Patient demographics
Eighty-one patients with large vessel, anterior circulation occlusion who were treated with Solitaire revascularization devices were analyzed. Patient demographic distributions are summarized in Table 1 Clinical outcomes according to whether preceding
IV-tPA
In patients who were treated IA-Tx after receiving IV-tPA, the recanalization rate was 34 (81.0%) and the sICH rate was 8 (19.0%), while these rates were 27
(69.2%) and 10 (25.6%) in patients who were treated with IA-Tx without IV-tPA (p = 0.167 and p = 0.328, respectively; Table 2 ). Neurologic outcomes were not statistically significant between the IV-tPA treated and non-treated groups (p > 0.05; Table 2 ). Values are presented as mean ± SD or number (%). tPA = tissue plasminogen activator; SD = standard deviation; NIHSS = National Institutes of Health Stroke Scale; IV-tPA = intravenous tissue plasminogen activator; MCA = middle cerebral artery; Lt. = left; Rt. = right; ICA = internal cerebral artery; mRS = modified Rankin Scale; ICH = intracerebral hemorrhage; OP = operation The mean initial neurologic status (evaluated with NIHSS) was 11.1 ± 4.9 (median, 10) in P/D-mismatched patients while it was 15.6 ± 3.7 (median, 15) in P/D-matched patients (p = 0.255). The recanalization rate was 54 (91.9%) and the sICH rate was 11 (16.7%) in P/D-mismatched patients, while it was 7 (46.7%) and 7 (46.7%) in P/D-matched patients (p = 0.008 and p = 0.019, respectively, Table 3 ). Neurologic outcomes for P/D-mismatched patients, 46 (69.7%) patients was favorable, and no patients died, but 0 (0%) had a favorable outcome and 6 (40%) died in P/D-matched patients (p = 0.000 and p = 0.001, respectively; Fig. 2 ).
Clinical outcomes according to weather P/D-mismatching
Hemorrhagic complications
In patients who were treated with IA-Tx prior to IV-tPA, the sICH rate was 8 (19.0%), while it was 10 (25.6%) in patients who did not receive IV-tPA (p > 0.05; Table 2 ). In IA-Tx with retrieval stent, IV-tPA treatment had no influence on the sICH incidence (x 2 , p = 0.328).
Additional decompression surgery
In 8 (9.9%) patients, all of the surgery indicated patient, an additional surgical decompression was performed after IA-Tx. Among these patients, 2 (3.0%)
patients showed P/D-mismatched and 6 (40.0%) showed P/D-matching (p = 0.000). Of these patients 4 (9.5%)
were IV-tPA treated and 4 (10.3%) patients did not receive IV-tPA (p = 0.601).
DISCUSSION
The main goal of cerebral ischemic stroke treatment is reopening of the occluded vessels before the critical cell damage happens. Recanalization of the occluded artery may allow reperfusion and improve the clinical outcome by saving vulnerable tissues namely the ischemic penumbra.
2)8) 25) Until the end of 2014, the only specific therapy for acute ischemic stroke was IV-tPA up to 4.5 hours after symptom onset. However, patients with occlusions of large, proximal, intracranial arteries are not typi- Although P/D-mismatching is an imaging selection tool for use in patients with acute ischemic stroke, there are some practical drawbacks. DWI imaging provides the most accurate assessment of the ischemic core, but the time taken to screen the patient for metallic implants and access to the scanner also needs to be considered. In this study, the authors found that, although beyond time to IV-tPA, some P/D-mismatched patients showed recanalization, low hemorrhagic complication rate and favorable outcome. The mortality rate was somewhat low in this study.
Decompressive surgery might be helpful for decreasing the mortality caused by major stroke, even though it may not improve neurologic outcomes for survivors. Decompression surgery in proper time should be performed to improve the neurologic outcome for acute stroke patient caused by the larger vessel occlusion.
CONCLUSION
As previous reports, P/D-mismatching was correlated well with the recanalization rate, hemorrhagic complication rate and clinical outcomes. In our study, also confirm the clinical significance the P/D-mismatching.
And authors would like to insist that IV-tPA infusion before the IA-Tx, did not increase hemorrhagic complication rate.
